These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24227361)

  • 21. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Yoo J; Kim BS; Yoon HJ
    Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    Hung WK; Ying M; Chan M; Mak KL; Chan LK
    Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinoma in situ.
    Zetterlund L; Stemme S; Arnrup H; de Boniface J
    Br J Surg; 2014 Apr; 101(5):488-94. PubMed ID: 24493058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
    Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
    Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
    Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
    Kurniawan ED; Rose A; Mou A; Buchanan M; Collins JP; Wong MH; Miller JA; Mann GB
    Arch Surg; 2010 Nov; 145(11):1098-104. PubMed ID: 21079099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
    Houssami N; Ambrogetti D; Marinovich ML; Bianchi S; Macaskill P; Vezzosi V; Mamounas EP; Ciatto S
    Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.
    Pleijhuis RG; Kwast AB; Jansen L; de Vries J; Lanting R; Bart J; Wiggers T; van Dam GM; Siesling S
    Breast; 2013 Oct; 22(5):773-9. PubMed ID: 23462681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
    Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
    J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
    McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
    Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
    Tan JC; McCready DR; Easson AM; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
    Sorrentino L; Sartani A; Bossi D; Amadori R; Nebuloni M; Truffi M; Bonzini M; Riggio E; Foschi D; Corsi F
    Breast J; 2018 May; 24(3):325-333. PubMed ID: 29024241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.
    Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S502-8. PubMed ID: 26059650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.